Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca J Bluett

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cell Reports|June 13, 2025
Edinger-Westphal Urocortin-1 neurons regulate consumption and affectRebecca J Bluett, Ying Yu, Jordan L Pauli, et al.
Biological Psychiatry|July 28, 2015
The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency ModelsSachin Patel, Brian C Shonesy, Rebecca J Bluett, et al.
Neuropharmacology|December 29, 2015
Acute and chronic ethanol exposure differentially regulate CB1 receptor function at glutamatergic synapses in the rat basolateral amygdalaStacey L Robinson, Nancy J Alexander, Rebecca J Bluett, et al.
Neuropharmacology|June 18, 2014
The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injuryFlaubert Tchantchou, Laura B Tucker, Amanda H Fu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2021
Endogenous cannabinoids are required for MC4R-mediated control of energy homeostasisYu Yong, Isin Cakir, Pauline Lining Pan, et al.
Neuron|March 11, 2014
Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapsesTeniel S Ramikie, Rita Nyilas, Rebecca J Bluett, et al.
Translational Psychiatry|April 27, 2018
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitorsGaurav Bedse, Rebecca J Bluett, Toni A Patrick, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 12, 2016
Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive-Like Behavior During Forced Abstinence From Alcohol DrinkingKatherine M Holleran, Hadley H Wilson, Tracy L Fetterly, et al.
Cell Reports|December 4, 2014
Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulationBrian C Shonesy, Rebecca J Bluett, Teniel S Ramikie, et al.
Current Biology : CB|April 24, 2018
Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the MidbrainJennifer M Wenzel, Erik B Oleson, Willard N Gove, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cell Reports|June 13, 2025
Edinger-Westphal Urocortin-1 neurons regulate consumption and affectRebecca J Bluett, Ying Yu, Jordan L Pauli, et al.
Biological Psychiatry|July 28, 2015
The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency ModelsSachin Patel, Brian C Shonesy, Rebecca J Bluett, et al.
Neuropharmacology|December 29, 2015
Acute and chronic ethanol exposure differentially regulate CB1 receptor function at glutamatergic synapses in the rat basolateral amygdalaStacey L Robinson, Nancy J Alexander, Rebecca J Bluett, et al.
Neuropharmacology|June 18, 2014
The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injuryFlaubert Tchantchou, Laura B Tucker, Amanda H Fu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2021
Endogenous cannabinoids are required for MC4R-mediated control of energy homeostasisYu Yong, Isin Cakir, Pauline Lining Pan, et al.
Neuron|March 11, 2014
Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapsesTeniel S Ramikie, Rita Nyilas, Rebecca J Bluett, et al.
Translational Psychiatry|April 27, 2018
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitorsGaurav Bedse, Rebecca J Bluett, Toni A Patrick, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 12, 2016
Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive-Like Behavior During Forced Abstinence From Alcohol DrinkingKatherine M Holleran, Hadley H Wilson, Tracy L Fetterly, et al.
Cell Reports|December 4, 2014
Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulationBrian C Shonesy, Rebecca J Bluett, Teniel S Ramikie, et al.
Current Biology : CB|April 24, 2018
Phasic Dopamine Signals in the Nucleus Accumbens that Cause Active Avoidance Require Endocannabinoid Mobilization in the MidbrainJennifer M Wenzel, Erik B Oleson, Willard N Gove, et al.
Pageof 2